Stop a common heart rhythm with surgery add-on therapy
Part of Heart & circulation clinical trials.
This study looks at whether an added heart device approach around the time of planned open-heart surgery can help treat non-paroxysmal atrial fibrillation (AF), a long-lasting irregular heartbeat. It may help lower ongoing AF burden in people who also need non-emergency heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have persistent or longstanding persistent atrial fibrillation (AF), not brief episodes only
- You are already scheduled for non-emergency open-heart surgery (like bypass or valve repair/replacement)
- You can safely take blood thinners such as warfarin or a DOAC/NOAC
- You have not had prior AF ablation, AV-node ablation, or a surgical Maze procedure
- Your heart function and health status fit the study limits (for example, not very weak heart function)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an extra heart ablation procedure for people with persistent atrial fibrillation. It aims to improve the success of the standard treatment by also isolating the back wall of the left atrium, which may help keep your heart rhythm normal longer.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
This study compares two different ablation procedures (treatments that target heart rhythm triggers) for people with atrial fibrillation and reduced heart pumping. It aims to see which approach works best and is safest for improving your heart rhythm when you also have heart failure.
This study compares two ways to treat persistent atrial fibrillation (an irregular heartbeat that lasts for a long time). One method uses a catheter to treat the heart from the inside, and the other combines that with a small procedure on the outside of the heart. The goal is to see which approach works better for people whose symptoms haven't improved with medication.
This trial tests a new device used during open-heart surgery to treat atrial fibrillation (AFib) by delivering tiny, fast electrical pulses to the heart tissue. It is for people who are already having heart surgery and want to also treat their AFib at the same time.
This study looks at what happens in the heart in people with persistent atrial fibrillation when they undergo an ablation or Maze surgery. It may help doctors better understand the condition and improve future care for people needing these procedures.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.